Discussion
Kyverna Therapeutics and ElevateBio have signed a manufacturing and supply agreement for mivocabtagene autoleucel (miv-cel), Kyverna’s experimental CAR T-cell therapy for people with generalized myasthenia gravis (gMG). The new agreement covers both U.S.